カテゴリ： MarketLine, アメリカ, 企業調査

HollyFrontier Corporation：企業の戦略・SWOT・財務分析

◆英語タイトル：HollyFrontier Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY5043
◆発行会社（調査会社）：MarketLine
◆発行日：2020年2月
◆ページ数：44
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：Energy and Utilities
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

HollyFrontier Corporation – Strategy, SWOT and Corporate Finance Report
Summary

HollyFrontier Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

HollyFrontier Corporation (HollyFrontier or ‘the company’) is a petroleum refining company in the US. The company offers products such as specialty lubricant products, diesel fuel, gasoline, jet and diesel fuels. It is also into refining and wholesale marketing of refined petroleum and crude oil products. The company manages its refineries at El Dorado, Tulsa, Navajo, Cheyenne and Woods Cross Refineries and HFC Asphalt. The company manages Southwest, Rocky Mountain and Mid-Continent logistic assets in the US. The company has its presence in the US. The company is headquartered in Dallas, Texas, the US.

Scope

- Detailed information on HollyFrontier Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting HollyFrontier Corporation in the form of a SWOT analysis
- An in-depth view of the business model of HollyFrontier Corporation including a breakdown and examination of key business segments
- Intelligence on HollyFrontier Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about HollyFrontier Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of HollyFrontier Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess HollyFrontier Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on HollyFrontier Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
HollyFrontier Corporation: Company Overview
HollyFrontier Corporation: Overview and Key Facts
HollyFrontier Corporation: Overview
HollyFrontier Corporation: Key Facts
HollyFrontier Corporation: Key Employees
HollyFrontier Corporation: Key Employee Biographies
HollyFrontier Corporation: Major Products and Services
HollyFrontier Corporation: Company History
HollyFrontier Corporation: Management Statement
HollyFrontier Corporation: Locations and Subsidiaries
HollyFrontier Corporation: Key Competitors
HollyFrontier Corporation: Company Analysis
HollyFrontier Corporation: Business Description
HollyFrontier Corporation: SWOT Analysis
HollyFrontier Corporation: SWOT Overview
HollyFrontier Corporation: Strengths
HollyFrontier Corporation: Weaknesses
HollyFrontier Corporation: Opportunities
HollyFrontier Corporation: Threats
HollyFrontier Corporation: Corporate Financial Deals Activity
HollyFrontier Corporation: Financial Deals Overview
HollyFrontier Corporation: Targets and Partners
HollyFrontier Corporation: Top Deals 2016 – 2020YTD*
HollyFrontier Corporation: Advisors
HollyFrontier Corporation: Top Legal Advisors
HollyFrontier Corporation: Mergers and Acquisitions
HollyFrontier Corporation: Capital Raising
HollyFrontier Corporation: Divestments
HollyFrontier Corporation: Recent Developments
HollyFrontier Corporation: News and Events Summary
HollyFrontier Corporation: Business Expansion
HollyFrontier Corporation: Contracts
HollyFrontier Corporation: Financial Performance
HollyFrontier Corporation: Regulatory and Legal Events
HollyFrontier Corporation: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: HollyFrontier Corporation: Key Facts
Table 2: HollyFrontier Corporation: Key Employees
Table 3: HollyFrontier Corporation: Company History
Table 4: HollyFrontier Corporation: Locations and Subsidiaries
Table 5: HollyFrontier Corporation: Key Competitors
Table 6: HollyFrontier Corporation: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: HollyFrontier Corporation: M&A Average Deal Size - Value (US$m)
Table 8: HollyFrontier Corporation: Targets and Partners
Table 9: HollyFrontier Corporation: Top Deals 2016 - 2020YTD*
Table 10: HollyFrontier Corporation: Legal Advisor Ranking by Value (US$m)
Table 11: HollyFrontier Corporation: M&A Volume and Value Trend (2016 - YTD*2020)
Table 12: HollyFrontier Corporation: M&A Activity by Geography (2016 - YTD*2020)
Table 13: HollyFrontier Corporation: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 14: HollyFrontier Corporation: Capital Raising by Deal Type (2016 - YTD*2020)
Table 15: HollyFrontier Corporation: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 16: HollyFrontier Corporation: Divestments by Geography (2016 - YTD*2020)
Table 17: HollyFrontier Corporation: News and Events Summary
Table 18: HollyFrontier Corporation: Business Expansion
Table 19: HollyFrontier Corporation: Contracts
Table 20: HollyFrontier Corporation: Financial Performance
Table 21: HollyFrontier Corporation: Regulatory and Legal Events
Table 22: HollyFrontier Corporation: Strategy and Operations

★海外企業調査レポート[HollyFrontier Corporation：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Companhia Energetica de Minas Gerais SA (CMIG4)：企業の財務・戦略的SWOT分析
    Companhia Energetica de Minas Gerais SA (CMIG4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Boston Children’s Hospital：企業の戦略的SWOT分析
    Boston Children's Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • The Boston Beer Co Inc (SAM)：企業の財務・戦略的SWOT分析
    The Boston Beer Co Inc (SAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Royal DSM NV (DSM)-製薬・医療分野：企業M&A・提携分析
    Summary Royal DSM NV (DSM) is a life sciences and materials sciences company, which focuses on health, nutrition and materials sectors. The company offers a wide range of products such as anti-invectives, polyesters, vitamins and other ingredients, performance materials to diverse end markets. It pr …
  • Encore Dermatology Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Encore Dermatology Inc (Encore Dermatology) is a specialty dermatology company, which develops and commercializes novel prescription medicines and medical devices for the treatment of topical dermatological disorders. The company’s products include HylatopicPlus lotion, a combination of vari …
  • EOG Resources, Inc.：企業の戦略・SWOT・財務情報
    EOG Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary EOG Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Legian Beach Hotel
    Legian Beach Hotel - Strategy, SWOT and Corporate Finance Report Summary Legian Beach Hotel - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • WInco Foods LLC：戦略・SWOT・企業財務分析
    WInco Foods LLC - Strategy, SWOT and Corporate Finance Report Summary WInco Foods LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Cigna Corp (CI)：企業の財務・戦略的SWOT分析
    Cigna Corp (CI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Corline Biomedical AB (CLBIO)：製薬・医療：M&Aディール及び事業提携情報
    Summary Corline Biomedical AB (Corline Biomedical), formerly Corline Systems AB is a manufacturer of heparin based solutions. The company offers heparin based solutions to improve kidney transplantation, and applications in the field of regenerative medicine. Its regentrative medicines include cytop …
  • ContraVir Pharmaceuticals Inc (CTRV)：企業の財務・戦略的SWOT分析
    Summary ContraVir Pharmaceuticals Inc (ContraVir) is a biopharmaceutical company that offers development and commercialization of targeted antiviral therapies. The company provides pipeline product such as TXL, potent prodrug of antiviral tenofovir and CRV431 cyclophilin inhibitor that increases its …
  • Hewlett Packard Enterprise Company：企業の戦略・SWOT・財務情報
    Hewlett Packard Enterprise Company - Strategy, SWOT and Corporate Finance Report Summary Hewlett Packard Enterprise Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • MEC Holding GmbH：企業の戦略的SWOT分析
    MEC Holding GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Cocoon Holdings Ltd (428)：企業の財務・戦略的SWOT分析
    Cocoon Holdings Ltd (428) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Consolidated Edison Company of New York, Inc.-エネルギー分野：企業M&A・提携分析
    Summary Consolidated Edison Company of New York, Inc. (CECONY), a subsidiary of Consolidated Edison, Inc. is an energy utility that generates, transmits and distributes electricity; supplies natural gas; and generates and supplies steam. The company provides electricity and related services in New Y …
  • Siemens Heat Transfer Technology BV：企業の戦略的SWOT分析
    Siemens Heat Transfer Technology BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Formula Pharmaceuticals Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Formula Pharmaceuticals Inc (Formula Pharmaceuticals) is a biopharmaceutical company that develops chimeric antigen receptor immunotherapy for oncology and autoimmune diseases. The company provides its pipeline products such as CIK-CAR.CD19, used as B-lymphocyte surface antigen; CIK-CAR.CD33 …
  • Bristol-Myers Squibb Co (BMY)-製薬・医療分野：企業M&A・提携分析
    Summary Bristol-Myers Squibb Company (BMS) is specialty biopharmaceutical company that carries out the discovery, development, licensing, manufacturing, marketing, distribution and sale of medicines to patients with serious diseases. Its primary focus is in cancer, cardiovascular, immunoscience and …
  • Fiesta Mart LLC：企業の戦略的SWOT分析
    Fiesta Mart LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Sentara Healthcare Inc：企業の戦略的SWOT分析
    Sentara Healthcare Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆